Cargando…
Active Targeted Nanoformulations via Folate Receptors: State of the Art and Future Perspectives
In normal tissues, the expression of folate receptors is low and limited to cells that are important for embryonic development or for folate reabsorption. However, in several pathological conditions some cells, such as cancer cells and activated macrophages, overexpress folate receptors (FRs). This...
Autores principales: | Martín-Sabroso, Cristina, Torres-Suárez, Ana Isabel, Alonso-González, Mario, Fernández-Carballido, Ana, Fraguas-Sánchez, Ana Isabel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781617/ https://www.ncbi.nlm.nih.gov/pubmed/35056911 http://dx.doi.org/10.3390/pharmaceutics14010014 |
Ejemplares similares
-
Antibody-Antineoplastic Conjugates in Gynecological Malignancies: Current Status and Future Perspectives
por: Martín-Sabroso, Cristina, et al.
Publicado: (2021) -
PLGA Nanoparticles for the Intraperitoneal Administration of CBD in the Treatment of Ovarian Cancer: In Vitro and In Ovo Assessment
por: Fraguas-Sánchez, Ana I., et al.
Publicado: (2020) -
Development of Innovative Formulations for Breast Cancer Chemotherapy
por: Fraguas-Sánchez, Ana Isabel, et al.
Publicado: (2020) -
Limitations and Challenges in the Stability of Cysteamine Eye Drop Compounded Formulations
por: Martín-Sabroso, Cristina, et al.
Publicado: (2021) -
Actively Targeted Nanomedicines in Breast Cancer: From Pre-Clinal Investigation to Clinic
por: Fraguas-Sánchez, Ana Isabel, et al.
Publicado: (2022)